文献速递炎症性肠病

溃疡性结肠炎PICaSSO组织学缓解指数(PHRI):一种用于监测黏膜愈合、预测临床结局并适用于人工智能系统的新型简化组织学评分

PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system.
PubMed 文献 · Gut · 2022-02-16

基于307例溃疡性结肠炎(UC)患者的前瞻性多中心研究,开发了与内镜对齐、与临床结局相关的简化组织学指数PHRI。PHRI与内镜评分和临床结局强相关,评分1可分层12个月内不良结局风险,读者间一致性高(组内相关系数0.84)。初步人工智能算法区分活动性与静止期UC的敏感度78%、特异度91.7%、准确率86%。

要点

  • PHRI与内镜评分(Mayo内镜评分、UC内镜严重指数、PICaSSO)及临床结局强相关。
  • PHRI评分1可准确分层12个月内住院、结肠切除和治疗优化的风险。
  • 初步AI算法区分活动性与静止期UC的敏感度78%、特异度91.7%、准确率86%。

核心结论

  • PHRI是UC的一种简单组织学指数,与内镜活动和临床结局的相关性最高。
  • 基于PHRI的人工智能系统在预测组织学缓解方面准确。

研究设计与样本

  • 使用前瞻性多中心研究纳入的307例UC患者的614份活检组织开发PHRI。
  • 评估PHRI与多种其他组织学指数的一致性及读者间可重复性验证。
  • 使用138份活检子集训练和测试基于CNN架构的深度学习策略,以检测中性粒细胞、计算PHRI并区分活动性与静止期UC。

主要发现

  • PHRI与内镜评分(Mayo内镜评分、UC内镜严重指数和PICaSSO)及临床结局(住院、结肠切除、因UC flare-up而开始或改变药物治疗)强相关。
  • PHRI评分1可准确分层12个月内不良结局(住院、结肠切除和因flare-up而治疗优化)的风险。
  • 读者间一致性高(组内相关系数0.84)。
  • 初步AI算法区分活动性与静止期UC的敏感度78%、特异度91.7%、准确率86%。

关键数值与推荐

  • PHRI评分1可准确分层12个月内不良结局风险。
  • 读者间组内相关系数0.84。
  • AI算法敏感度78%、特异度91.7%、准确率86%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Histological remission is evolving as an important treatment target in UC. We aimed to develop a simple histological index, aligned to endoscopy, correlated with clinical outcomes, and suited to apply to an artificial intelligence (AI) system to evaluate inflammatory activity. METHODS: Using a set of 614 biopsies from 307 patients with UC enrolled into a prospective multicentre study, we developed the Paddington International virtual ChromoendoScopy ScOre (PICaSSO) Histologic Remission Index (PHRI). Agreement with multiple other histological indices and validation for inter-reader reproducibility were assessed. Finally, to implement PHRI into a computer-aided diagnosis system, we trained and tested a novel deep learning strategy based on a CNN architecture to detect neutrophils, calculate PHRI and identify active from quiescent UC using a subset of 138 biopsies. RESULTS: PHRI is strongly correlated with endoscopic scores (Mayo Endoscopic Score and UC Endoscopic Index of Severity and PICaSSO) and with clinical outcomes (hospitalisation, colectomy and initiation or changes in medical therapy due to UC flare-up). A PHRI score of 1 could accurately stratify patients' risk of adverse outcomes (hospitalisation, colectomy and treatment optimisation due to flare-up) within 12 months. Our inter-reader agreement was high (intraclass correlation 0.84). Our preliminary AI algorithm differentiated active from quiescent UC with 78% sensitivity, 91.7% specificity and 86% accuracy. CONCLUSIONS: PHRI is a simple histological index in UC, and it exhibits the highest correlation with endoscopic activity and clinical outcomes. A PHRI-based AI system was accurate in predicting histological remission.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Gui X, Bazarova A, Del Amor R, et al. PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system. Gut. 2022. PMID: 35173041. doi:10.1136/gutjnl-2021-326376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。